Related Experiment Video
Updated: Oct 4, 2025

02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
528
Data Mining and Meta-Analysis of Psoriasis Based on Association Rules
1Department of Detmatology Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Journal of Healthcare Engineering
|February 7, 2022
Summary
Defubao is an effective topical treatment for psoriasis vulgaris, outperforming calcipotriol and betamethasone. Longer treatment durations (8 weeks) show significantly better results and improved safety profiles compared to shorter periods.
Area of Science:
- Dermatology
- Pharmacology
- Data Mining
Background:
- Psoriasis vulgaris is a chronic dermatological condition significantly impacting patient well-being.
- Evaluating treatment efficacy and safety is crucial for managing psoriasis vulgaris.
- Existing data mining algorithms like Apriori have limitations in efficiency and data handling.
Purpose of the Study:
- To evaluate the effectiveness and safety of topical defubao for psoriasis vulgaris through meta-analysis.
- To introduce a novel matrix association rule method based on random forest weighting for improved data analysis.
- To compare defubao with calcipotriol and betamethasone in treating psoriasis vulgaris.
Main Methods:
- Included 11 studies evaluating topical defubao for psoriasis vulgaris.
- Utilized efficacy indicators: Investigator's Global Assessment (IGA), Patient's Global Assessment (PGA), and Psoriasis Area and Severity Index (PASI).
- Employed a matrix association rule method with random forest weighting for data analysis and efficiency.
Main Results:
- Defubao demonstrated superior treatment effects compared to calcipotriol and betamethasone, with statistically significant differences (IGA, PGA).
- An 8-week defubao treatment duration yielded significantly better outcomes than 4-week or 2-week durations.
- Defubao treatment resulted in a higher average PASI reduction rate after 4 weeks and a significantly lower incidence of adverse events after 8 weeks compared to calcipotriol.
Conclusions:
- Topical defubao is an effective and safe treatment for psoriasis vulgaris.
- Defubao shows significant advantages over calcipotriol and betamethasone in efficacy and safety.
- Longer treatment durations (8 weeks) enhance defubao's therapeutic benefits and safety profile.

